The National Health Service is poised for what health chiefs are describing as a radical reset, prioritising a digital-first approach to urgent and emergency care. As part of a three-year
NHS4- Page
165Articles
The ongoing dispute between junior doctors and the government has reached a critical juncture as resident doctors—formerly known as junior doctors—have confirmed a five-day walkout over pay and job security
Weight loss injections have rapidly transformed the British approach to tackling obesity, with an extraordinary surge in private usage. Latest data suggests that 2.5 million adults in the UK—one in
Senior figures within the British Medical Association (BMA) have ignited fierce debate following the leak of a letter suggesting that GPs should direct patients to A and E departments rather
Senior doctors are warning that the NHS is in a state of emergency despite Chancellor Rachel Reeves injecting an additional £25 billion into the health service this year. Labour has
John Lewis has secured unanimous approval for a £70 million build to rent project in Reading, following significant debate over the impact on local health services and affordable housing provision.
Sir Keir Starmer is preparing to overhaul NHS value for money protocols in a high-stakes move that could see Britain pour billions more into pharmaceutical spending. This comes amid escalating
Prime Minister Sir Keir Starmer is set to announce a major transformation of the NHS with the unveiling of a new virtual hospital service. During his speech at the Labour
The UK pharmaceutical sector, long celebrated as a linchpin of the British economy, now faces an unprecedented crisis following the imposition of sweeping new tariffs by Donald Trump. In a
Moderna has marked a significant milestone in the UK pharmaceuticals landscape by launching a £150m manufacturing and research facility in Oxfordshire. The ribbon-cutting ceremony, attended by Moderna’s chief executive Stéphane
NHS staff outperformed government expectations last year, delivering a sharp improvement in productivity and offering a timely win for Chancellor Rachel Reeves ahead of the crucial autumn Budget. For the
Recent public announcements of cancer diagnoses by high-profile figures have inadvertently contributed to significant delays in the National Health Service’s cancer referral process, a senior coroner has observed. Samantha Goward,
Bristol Myers Squibb BMS has issued a pointed demand for the NHS to fund a greater share of pharmaceutical innovation calling for the UK to pay what it describes as
The National Health Service is making a significant stride towards modernising diagnostics with the introduction of a cloud-based screening platform designed to accelerate the identification of chronic diseases. With an
The battle between the NHS and pharmaceutical giants is reaching boiling point as accusations fly over the UK’s approach to funding modern medicines. A fresh row has ignited during President
Britain’s pharmaceutical sector has been thrust into sharp focus as the government pledges urgent action to resolve a standoff with multinational drug companies. In the aftermath of several high-profile withdrawals
